The indicative function of Twist2 and E-cadherin in HPV oncogene-induced epithelial-mesenchymal transition of cervical cancer cells

Oncology Reports

Volumn 33, Issue 2, 2015, Pages 639-650

  Liu, Yuan ^a   Qian, Wenyan ^b   Zhang, Jiawen ^c   Dong, Yu ^a   Shi, Can ^a   Liu, Zhiqiang ^d   Wu, Sufang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c TONGJI UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cervical cancer; E cadherin; Epithelial mesenchymal transition; Human papillomavirus 16; Twist2

Indexed keywords

PROTEIN E2; PROTEIN E6; PROTEIN E7; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST2; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; VIRUS PROTEIN; CADHERIN; REPRESSOR PROTEIN; TWIST2 PROTEIN, HUMAN; VIRUS ANTIGEN;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CELL INVASION; CELLULAR DISTRIBUTION; CERVICAL CANCER CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; ONCOGENE; PROTEIN EXPRESSION; TISSUE MICROARRAY; UPREGULATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; PAPILLOMAVIRUS INFECTION; PATHOLOGY; TUMOR INVASION; UTERINE CERVIX TUMOR; VIROLOGY;

ANTIGENS, VIRAL; CADHERINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEOPLASM INVASIVENESS; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; TWIST TRANSCRIPTION FACTOR; UTERINE CERVICAL NEOPLASMS; VIMENTIN;

EID: 84919458936     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3620     Document Type: Article

References (42)

1. Zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350, 2002.
2. Faridi R, Zahra A, Khan K and Idrees M: Oncogenic potential of human papillomavirus (HPV) and its relation with cervical cancer. Virol J 8: 269, 2011.
3. Panjkovic M and Ivkovic-Kapicl T: Etiology and pathoGenesis of precancerous lesions and invasive cervical carcinoma. Med Pregl 61: 364-368, 2008 (In Serbian).
4. Snijders PJ, Steenbergen RD, Heideman DA and Meijer CJ: HPV-mediated cervical carcinoGenesis: concepts and clinical implications. J Pathol 208: 152-164, 2006.
5. Javier MG and Sastre-Garau X: uterine cervix carcinoma: recent biological data and update for improving follow-up and treatment. Isr Med Assoc J 14: 700-704, 2012.
6. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B and Tommasino M: The biological properties of E6 and E7 oncop-roteins from human papillomaviruses. Virus Genes 40: 1-13, 2010.
7. De Craene B and Berx G: Regulatory networks defning EMT during cancer initiation and progression. Nat Rev Cancer 13: 97-110, 2013.
8. Stewart CJ and McCluggage WG: Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology 62: 31-43, 2013.
9. Lim J and Thiery JP: Epithelial-mesenchymal transitions: insights from development. Development 139: 3471-3486, 2012.
10. Le Bras GF, Taubenslag KJ and Andl CD: The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adh Migr 6: 365-373, 2012.
11. Rodriguez FJ, Lewis-Tuffn LJ and Anastasiadis PZ: E-cadherin's dark side: possible role in tumor progression. Biochim Biophys Acta 1826: 23-31, 2012.
12. Iwatsuki M, Mimori K, Yokobori T, et al: Epithelial-mesenchymal transition in cancer development and its clinical signifcance. Cancer Sci 101: 293-299, 2010.
13. Sanchez-Tillo E, Liu Y, De Barrios O, et al: EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 69: 3429-3456, 2012.
14. Lee MY and Shen MR: Epithelial-mesenchymal transition in cervical carcinoma. Am J Transl Res 4: 1-13, 2012.
15. Li Y, Wang W, Wang W, et al: Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumoriGenesis and progression of cervical carcinoma. Gynecol Oncol 124: 112-118, 2012.
16. Chamulitrat W, Schmidt R, Chunglok W, Kohl A and Tomakidi P: Epithelium and fbroblast-like phenotypes derived from HPV16 E6/E7-immortalized human gingival keratinocytes following chronic ethanol treatment. Eur J Cell Biol 82: 313-322, 2003.
17. Hellner K, Mar J, Fang F, Quackenbush J and Munger K: HPV16 E7 Oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesen-chymal transition. Virology 391: 57-63, 2009.
18. Cheng YM, Chou CY, Hsu YC, Chen MJ and Wing LY: The role of human papillomavirus type 16 E6/E7 oncoproteins in cervical epithelial-mesenchymal transition and carcinoGenesis. Oncol Lett 3: 667-671, 2012.
19. Caberg JH, Hubert PM, Begon DY, et al: Silencing of E7 Oncogene restores functional E-cadherin expression in human papil-lomavirus 16-transformed keratinocytes. CarcinoGenesis 29: 1441-1447, 2008.
20. Mühlen S, Behren A, Iftner T and Simon C: Influence of HPV16 E2 and its localisation on the expression of matrix metal-loproteinase-9. Int J Oncol 37: 337-345, 2010.
21. Zhang J, Yang Y, Zhang Z, et al: Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway. Cancer Lett 339: 279-287, 2013.
22. Wang YX, Zhang XY, Zhang BF, Yang CQ and Gao HJ: Study on the clinical signifcance of Argonaute2 expression in colonic carcinoma by tissue microarray. Int J Clin Exp Pathol 6: 476-484, 2013.
23. Franco HL, Casasnovas J, Rodriguez-Medina JR and Cadilla CL: Redundant or separate entities?-roles of Twist1 and Twist2 as molecular switches during gene transcription. Nucleic Acids Res 39: 1177-1186, 2011.
24. Zeisberg M and Neilson EG: Biomarkers for epithelial-mesen-chymal transitions. J Clin Invest 119: 1429-1437, 2009.
25. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
26. Gasparotto D, Polesel J, Marzotto A, et al: Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas. Oncotarget 2: 1165-1175, 2011.
27. Mao Y, Zhang N, Xu J, Ding Z, Zong R and Liu Z: Signifcance of heterogeneous Twist2 expression in human breast cancers. PloS One 7: e48178, 2012.
28. Myong NH: Loss of E-cadherin and acquisition of vimentin in epithelial-mesenchymal transition are noble indicators of uterine cervix cancer progression. Korean J Pathol 46: 341-348, 2012.
29. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006.
30. Reik W: Stability and fexibility of epigenetic gene regulation in mammalian development. Nature 447: 425-432, 2007.
31. Lee MY, Chou CY, Tang MJ and Shen MR: Epithelial-mesenchymal transition in cervical cancer: cor relation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 14: 4743-4750, 2008.
32. Hsu YM, Chen YF, Chou CY, et al: KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. Cancer Res 67: 11064-11073, 2007.
33. Van Roy F and Berx G: The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788, 2008.
34. Jung YS, Kato I and Kim HR: A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition. Biochem Biophys Res Commun 435: 339-344, 2013.
35. Watson RA, Thomas M, Banks L and Roberts S: Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J Cell Sci 116: 4925-4934, 2003.
36. Duffy CL, Phillips SL and Klingelhutz AJ: Microarray analysis identifes differentiation-associated Genes regulated by human papillomavirus type 16 E6. Virology 314: 196-205, 2003.
37. Thierry F: Transcriptional regulation of the papillomavirus Oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 384: 375-379, 2009.
38. Forma E, Wójcik-Krowiranda K, Bienkiewicz A and Brys M: Molecular basis of gynecological oncology-TopBP1 protein and its participation in the transcription process. Ginekol Pol 83: 363-367, 2012 (In Polish).
39. Bodily JM, Hennigan C, Wrobel GA and Rodriguez CM: Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle. Virology 443: 11-19, 2013.
40. Xue Y, Lim D, Zhi L, He P, Abastado JP and Thierry F: Loss of HPV16 E2 protein expression without disruption of the E2 ORF correlates with carcinogenic progression. Open Virol J 6: 163-172, 2012.
41. Ramirez-Salazar E, Centeno F, Nieto K, Valencia-Hernandez A, Salcedo M and Garrido E: HPV16 E2 could act as down-regulator in cellular Genes implicated in apoptosis, proliferation and cell differentiation. Virol J 8: 247, 2011.
42. Bellanger S, Tan CL, Xue YZ, Teissier S and Thierry F: Tumor suppressor or Oncogene? A critical role of the human papillo-mavirus (HPV) E2 protein in cervical cancer progression. Am J Cancer Res 1: 373-389, 2011.